Frazier Healthcare brings in experts to get more bang for its bucks in drugs and medical devices

Frazier Healthcare Ventures http://www.frazierhealthcare.com has hired a crew of big-name biotech and pharmaceutical executives to help figure out how to get more bang for its bucks in drugs and medical devices.

The Seattle-based venture investor, one of the nation’s largest health-care venture firms with $1.2 billion under management, is trying to adapt to the rough reality of biotech investing. The days are gone when a firm could sink $50 million into a startup, gather evidence a drug works, then take the company public at a value of $350 million. Most biotechs fail, and even success stories can gobble up $100 million and go public for a $150 million value — hardly the stuff of venture dreams.

By Luke Timmerman

Seattle Times business reporter

Full Story: http://seattletimes.nwsource.com/html/businesstechnology/2003268311_frazier21.html